MedTrace Logo

Evaluation of the CONDA Stent Retriever in Acute Ischemic Stroke

NCT07174505 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-09-16

No results posted yet for this study

Summary

The goal of this study is to evaluate the safety and performance of the CONDA stent retriever in patients with acute ischemic stroke due to large vessel occlusion, treated within 24 hours of symptom onset.

The main objectives are:

* To determine the rate of device success, defined as the ability of the CONDA retriever to reach the blocked vessel, be deployed and retrieved successfully, and facilitate reperfusion.
* To evaluate safety, measured as the rate of symptomatic intracranial hemorrhage within 24 hours of the procedure.

The use of CONDA in this study follows the same approach as other CE-marked stent retrievers. Supportive devices (such as long sheaths, guide catheters, balloon catheters, distal access catheters, the ANA funnel catheter, microcatheters, and microwires) may be used according to investigator preference and local practice, in line with their labeling and instructions for use.

Participants will:

* Be evaluated using standard clinical and imaging assessments to confirm eligibility.
* Undergo mechanical thrombectomy with the CONDA device, with or without supportive devices as selected by the treating physician.
* Have standard follow-up evaluations to assess treatment safety and effectiveness.

Conditions

  • Acute Ischemic Stroke
  • Large Vessel Occlusion

Interventions

DEVICE

Mechanical Thrombectomy using the CONDA Stent Retriever

Intravenous sedation, local or general anesthesia, and anticoagulation management will be administered following the institution's standard of care to ensure subject safety and comfort. These procedures should be applied to the target population at the discretion of the investigator and in accordance with clinical guidelines. The use of CONDA is no different than that established for other CE marked stent retrievers. The use of supportive devices including, long sheaths, guide catheters with our without balloons, distal access catheters, ANA funnel catheter, microcatheters and microwires, along with the CONDA device, will be guided by operator preference and/or center established practices. Operators are required to use these devices according to their labeling and instructions for use.

Sponsors & Collaborators

  • Anaconda Biomed S.L.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-01
Primary Completion
2026-10-01
Completion
2027-01-01

Countries

  • Hungary
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07174505 on ClinicalTrials.gov